INBRX-109
inhibrx
['sarcoma']
 so honored to share today presenting to the a new drug for patients with #chondrosarcoma hot off the press for #asco23 preclinical characterization and phase 1 trial results of inbrx-109, a third-generation, recombinant, humanized, death 
Chief, Early-Phase Drug Development|@SarahCannonDocs
#Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.